This protocol addresses patients with a benign esophageal tumor in the specific clinical context of an esophageal granular cell tumor. Tumor size is the central determinant of the management pathway.
Esophageal granular cell tumors are managed according to lesion size. Small lesions may be amenable to surveillance, while tumors reaching a defined size threshold become candidates for endoscopic removal. Larger tumors require a different management approach entirely.
For appropriately sized tumors, an endoscopic resection strategy is considered — however, the full decision criteria, size thresholds, sequencing, and alternative pathways are contained within the structured protocol.